Cambridge Capital Group: Investment Portfolio & Startup News
Cambridge Capital Group
To add a bio or update investment portfolio click update information.
Investment Portfolio


Fuse Diagnostics
15 Sept 2026
Fuse Diagnostics raises £1m in funding led by The FSE Group for instrument-free tests that detect pathogens outside the laboratory
Fuse Diagnostics develops rapid molecular diagnostic tests that detect pathogens and contaminants without specialist laboratory infrastructure. Its Flip platform pairs proprietary amplification technology with a low cost, disposable test design, giving industrial and research teams laboratory-quality results in the environments where testing is actually needed.


Semarion
31 Mar 2026
Semarion secures £2.9m in funding led by Parkwalk to accelerate cell-based drug discovery
Semarion develops cell assay technology that enables adherent cell models to be handled as assay-ready, barcoded reagents. Its platform is used by pharmaceutical and life sciences organisations to improve flexibility, scalability and data generation in drug discovery workflows.
Cambridge Capital Group
- 2(12 months)
- cambridgecapitalgroup.co.uk
More venture news
- 13 Nov 2026

JADEJADE secures £450k in funding led by GC Angels to help universities manage their international student recruitment agents
EquityHR - 10 Nov 2026

PlankyPlanky raises £6m in funding co-led by Innovation Global and Azimut to turn financial data into credit decisions
EquityFintech - 10 Nov 2026

AncepAncep raises £6m in funding led by Creandum to help insurance brokers cover the clients they’d normally turn down
EquityEnterprise